Epstein Secrets

ons taken at committee meetings. The Supervisory Board therefore always had extensive and well-founded information on all matters of significance in the Evonik Group. At its meeting in March, the Supervisory Board focused on examining the annual financial state- ments, which had first been considered in detail by

ember 10, 2015) 0/0 Stephan Gemkow 5/5 100 4/4 100 Prof. Barbara Grunwald 5/5 100 4/4 100 Ralf Hermann 5/5 100 8/8 100 3/4 75 0/0 Prof. Wolfgang A. Herrmann 5/5 100 Dieter Kitten 5/5 100 Steven Koltes 4/5 80 7/8 87.5 1/1 100 Frank Lbllgen 5/5 100 3/4 75 Dr. Siegfried Luther 5/5 100 4/4 100

ting, for example, from legal disputes such as claims for compensation, and from administrative proceedings and fines. In its operating busi- ness, the Evonik Group is exposed to liability risks, especially in connection with product liability, patent law, tax law, com- petition law, antitrust law and environmen

en (until April 30, 2014) 30 19 53 Prof. Barbara Grunewald 90 90 30 30 9 9 129 129 Ralf Hermann 90 90 58 58 10 9 158 157 Prof. Wolfgang A. Herrmann 90 90 5 95 95 Dieter Kleren 90 90 95 95 Steven Koltes 90 90 45 45 8 S 143 140 Frank Ldllgen (from May 1, 2014) 90 60 28 18

PPLEMENTARY INFORMATION Independent Auditor's Report Report on the Group Management Report We have audited the accompanying management report for the Evonik Group, which is combined with the management report of the company, Evonik Industries AG, Essen, for the business year from January 1 to December 31, 201

mercial Law at the University of Cologne Ralf Hermann, Herten Chairman of the Group Works Council of Evonik Industries AG b) RAG-Stiftung Prof. Wolfgang A. Herrmann, Freising President of Munich Technical University b) Bayerische Forschungsallianz GmbH (Chair) Dieter Kleren, Wesseling Chairman of the Works Co